Corient Capital Partners, LLC Catalent, Inc. Transaction History
Corient Capital Partners, LLC
- $1.34 Billion
- Q3 2022
A detailed history of Corient Capital Partners, LLC transactions in Catalent, Inc. stock. As of the latest transaction made, Corient Capital Partners, LLC holds 3,005 shares of CTLT stock, worth $177,745. This represents 0.02% of its overall portfolio holdings.
Number of Shares
3,005
Previous 3,005
-0.0%
Holding current value
$177,745
Previous $322,000
-0.0%
% of portfolio
0.02%
Previous 0.02%
Shares
7 transactions
Others Institutions Holding CTLT
# of Institutions
496Shares Held
165MCall Options Held
274KPut Options Held
1.03M-
Vanguard Group Inc Valley Forge, PA20.2MShares$1.2 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY15.4MShares$908 Million0.02% of portfolio
-
State Street Corp Boston, MA7.45MShares$441 Million0.02% of portfolio
-
Capital World Investors Los Angeles, CA6.4MShares$378 Million0.06% of portfolio
-
Barclays PLC London, X04.97MShares$294 Million0.09% of portfolio
About Catalent, Inc.
- Ticker CTLT
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 179,896,000
- Market Cap $10.6B
- Description
- Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...